Watch Demo

Lipid Modifying Drug Market Outlook 2022 - 2026

Daily Updated Industry Statistics and Top Emerging Trends about the Lipid Modifying Drug Industry

Global Lipid Modifying Drug Trends in 2022

Lipid Modifying Drug is part of Therapy and includes a number of sub-sectors such as Fibrates, Statins, Niacin and Bile Acid Sequestrant. You may also be interested in Anesthetics, Anti-Infective and Cardiovascular Drug.

Global sales of lipid-modifying medicines are projected to reach $7 billion in 2026, down slightly from $7.4 billion in 2021. Year-on-year growth since 2017 has been a modest 2.1%. South Korea is the largest market for lipid-modifying medicines, with sales of $1.7 billion in 2021. Spain, Italy and Germany hold the second, third and fourth positions in the rankings, respectively. Latvia saw a significant 11.2% year-on-year increase in sales since 2017, while New Zealand saw a 22.2% decline over the same period.

Marketing Banner

Top 10 countries

In 2022 major markets in the Lipid Modifying Drug Industry were:

Lipid Modifying Drug Market Data and Forecasts

How much the Lipid Modifying Drug industry is expected to grow to 2026?

Forecast: Lipid Modifying Medicine Sales in Greece
Forecast: Lipid Modifying Medicine Sales in Finland
Forecast: Lipid Modifying Medicine Sales in Sweden
Forecast: Lipid Modifying Medicine Sales in Portugal
More in Lipid Modifying Drug Industry for 2028

Global Lipid Modifying Drug Industry Database